Biotechnology

Biotechnology companies have turned towards the conception of complexes made of one monoclonal antibody joined by a linker to an active (cytotoxic or therapeutic) molecule. The monoclonal antibody, a specific protein of a determined biological target; is used to vectorise the active molecule.

Our company has the capacity to intervene in the conception of this complex, and more precisely on:

 The synthesis of the active molecule and of the linker
 The condensation between the active molecule and the linker
 The conjugation between the linker and the monoclonal antibody

Not to mention the fact that BIOS Chem has already provided these services for other clients.